The Food and Drug Administration (FDA) lately declared the approval of Dovato, the first complete two-drug HIV treatment program for folks that previously haven’t been on antiretroviral treatment.
The new drug is for people that don’t have any known or suspected resistance to the treatment, based on a press release trusted source. Currently, the treatment for HIV-positive people who haven’t been receiving antiretroviral therapy has been a three-drug regimen.
Why is Dovato Important?
It provides the potential for these individuals to take their two-drug regimen in one particular tablet. ViiV Healthcare developed the drug.
“Having a drug-sparing treatment available that uses fewer drugs is beneficial to patients who may have issues taking multiple medications over a long period of time,” said Dr. Debra Birnkrant, director of the FDA’s division of antiviral products, in the release.
However, this isn’t the first HIV only two-drug treatment ever invented.…